Biotech-Focused Fund Adds Million: Immunome Bet Surges
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Apply expense trends to adjust your budget, making proactive changes that reflect shifting costs and priorities.
22,036 articlesA leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Airgain's 2025 earnings outlook hinges on product mix, OEM momentum, and margin discipline. This guide breaks down th...
As markets shift and longevity rises, a financial advisor says you’re likely undervaluing the need for flexible incom...
When a top executive sells shares, investors tune in. This article breaks down what a recent move by Ladder Capital's...
Imagine a world where SpaceX launches an IPO in July. This article breaks down how a price target could form, the big...
A seasoned travel-points expert fell for a fake invitation, and thieves turned 330,000 miles into gift cards. This gu...
The housing market is a split landscape in March 2026: some areas surge with demand while others cool after sharp cor...
A sharp drop in Alphabet shares doesn’t erase its long-term potential. This guide explains why Buffett’s approach and...
Today’s pullback in microsoft stock sinking today has investors scanning headlines for AI, policy, and growth signals...
Investors watch WWDC 2026 with high expectations as Apple readies a major AI push. This preview outlines what’s at st...
As Ethereum gears up for a major tech upgrade, investors wonder if ETH is poised for a move. This guide breaks down w...
A senior Rogers Corp. executive sold 830 shares for about $113,000, sparking questions about what it means for the st...